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Abstract
Nowadays, the incidence of Alzheimer’s disease (AD) and type 2 diabetes (T2D) is increasing at an alarming rate. More and 
more studies have been investigating the relationship between these two diseases and are trying to find an effective treat-
ment. According to amyloid hypothesis, it is very necessary to find phenolic compounds with catechol moieties, which would 
inhibit the aggregation of amyloid β (Aβ) and human islet amyloid polypeptide (hIAPP), while also exhibiting antioxidant ac-
tivity and protective effect. We isolated rosmarinic acid (RA) from the plant Isodon japonicus (Burm.f.) H. Hara. Thioflavin T 
assay and transmission electron microscopy observation were carried out to evaluate the inhibitory effect of RA, caffeic acid, 
and 3,4-dihydroxyphenyllactic acid, which are the substructures of RA, on both Aβ and hIAPP fibrillization. 2,2-Diphenyl-1-
picrylhydrazyl assay was applied to test the antioxidant activity. RA showed inhibitory effect on both peptides and strong an-
tioxidant activity. These results suggest that the existence of catechol units plays an important role on the inhibitory activity. 
Therefore, RA will be a promising strategy to prevent AD and T2D.
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Alzheimer’s disease (AD) and diabetes are parallel chronic 
diseases arising from aging, and the incidence is at an alarm-
ing rate, thereby becoming a highly concerning global health 
issue. Insulin resistance is considered as a core feature of 
type 2 diabetes (T2D), and emerging as a potentially import-
ant feature of AD.1 Some environmental factors and suscep-
tibility genes lead to insulin resistance, which lets diabetes 
uncontrolled. Too much sugar remaining in the blood may 
also damage the vessels and organs including the brain, fur-
therly cause AD.2 T2D and AD can both lead to cognitive 
decline, as well as brain hypofunction, memory disturbance, 
blindness, and so on.
Although the exact pathological defects in AD and T2D 
remain unknown, the prevailing theories implicate that the 
aggregation of amyloid β (Aβ) and human islet amyloid 
polypeptide (hIAPP) leads to such diseases. Aβ is a peptide 
containing 36 to 43 amino acids, which are formed from 
cleavage of amyloid precursor protein. hIAPP is a 37-resi-
due regulatory peptide, also the major secretory product of 
β-cells. Both peptides show a similar aggregation principle, 
and the aggregation of Aβ causes the extreme shrinkage of 
cerebral cortex and hippocampus in the brain, while hIAPP 
aggregation leads to the β-cell destruction.
Isodon japonicus (Burm.f.) H. Hara (Labiatae) is often 
applied in traditional Chinese and Japanese medicine, and it 
mainly grows in Northeast Asia. The aerial part of the plant is 
often used for the treatment of gastrointestinal disorders,3 while 
its dried leaves show strong antioxidant activity,4 antiallergic 
activity,5 tanning activity,6 and melanogenic inhibitory activ-
ity.7 Besides diterpenoids, I. japonicus is also a rich source of 
phenolic compounds. Rosmarinic acid (RA) is one of the dom-
inant compounds in the plant, which is the dimer of caffeic acid 
(CA) and with two catechol moieties.
In our previous studies, we reported that 
4,5-di-O-caffeoylquinic acid and 3,4,5-tri-O-caffeoylquinic 
acid strongly inhibited the aggregation of Aβ42 in a dose-de-
pendent manner.8 Acteoside and oraposide were also found 
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to exhibit strong activities for inhibition of Aβ aggregation 
and antioxidant activity.9,10 Some phenolic compounds with 
catechol moieties were proved possessing the inhibitory 
activity on the aggregation of Aβ. Recently, we found that 
glucuronosylated flavonoids with a catechol moiety exhib-
ited potent inhibitory activity of Aβ and hIAPP aggrega-
tions.11 On the other hand, RA shows strong antioxidant 
activity, and it can be expected to possess more biological 
activities also. In this study, we aimed on investigating the 
protective effect of RA, CA, and 3,4-dihydroxyphenyllactic 
acid (DPA) (Figure 1), which are the substructures of RA, on 
both AD and T2D. We successfully found that RA displayed 
inhibitory activity on amyloid aggregation related to both 
diseases.
To determine the inhibitory activity of RA, CA, and DPA 
against Aβ and hIAPP fibrillizations, Thioflavin T (Th-T) 
assay was used to measure the efficiency of these com-
pounds. Among all the samples dealt with different concen-
tration, these compounds expressed the 
concentration-dependent effect on protein fibrillization. As 
shown in Figure 2(a)-(c), RA showed the most significant 
Figure 1. Chemical structures of RA, CA, and DPA. CA, caffeic 
acid; DPA, 3,4-dihydroxyphenyllactic acid; RA, rosmarinic acid. CA, 
caffeic acid; DPA, 3,4-dihydroxyphenyllactic acid; RA, rosmarinic 
acid.
Figure 2. Effect of RA, CA, and DPA on the Th-T fluorescence from Aβ and hIAPP. (a) Aβ42 with RA; (b) Aβ42 with CA; (c) Aβ42 with 
DPA; (d) hIAPP with RA; (e) hIAPP with CA; (f) hIAPP with DPA. Aβ, amyloid β; CA, caffeic acid; DPA, 3,4-dihydroxyphenyllactic acid; 
hIAPP, human islet amyloid polypeptide; RA, rosmarinic acid; Th-T, Thioflavin T.
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inhibitory activity on Aβ42 aggregation, whose IC50 value 
was 4.8 µM, while CA exhibited a stronger inhibitory activ-
ity (IC50 17.9 µM) than that of DPA on Aβ42 (IC50 31.2 µM). 
CA is also used as a positive control in our previous 
reports.8,10 Figure 2(d)–(f) depicts the inhibitory activity on 
hIAPP aggregation of RA, CA, and DPA. RA and CA showed 
the inhibitory effect on hIAPP fibrillization at IC50 3.1 and 
57.6 µM, respectively. The effect of DPA was not signifi-
cantly detected (IC50 >100 µM). But different from Aβ, the 
formation of hIAPP fibril mostly happened in the first 4-hour 
incubation, after reaching the maximum of Th-T fluores-
cence intensity at 4 hours, RA, CA, and DPA started exhibit-
ing the effect on the fibril formation of hIAPP relatively, and 
after 8 hours the hIAPP entered the stable phase.
Transmission electron microscopy (TEM) images indi-
cated the typical fibrillization of Aβ and hIAPP incubated 
with or without RA, CA, and DPA. Proteins incubated with-
out these compounds showed more intensive fibril formation 
than those incubated with the compounds. Figure 3(b) , (f) 
shows the ability of RA on inhibiting the fibril formation of 
Aβ42 and hIAPP which was the most significant with a 
sparse fibrillization image. CA (Figure 3(c) and (g)) and DPA 
(Figure 3(d) and (h)) also affect the aggregation of both pro-
tein fibrils, but not that strong as RA.
Polyphenols affect the aggregation of Aβ and hIAPP due 
to the block of the aromatic ring on π–π stacking12 and the 
connection of quinone (auto-oxidized from catechol unit) 
and amyloid monomer, due to Michael addition or the imine 
formation.13 In the structure of RA, two catechol moieties 
are involved, which indicate that more blocks and connec-
tion exist between RA and protein chains. Comparing DPA 
with CA containing a carbon double bond means that is more 
easily auto-oxidized, possessing a stronger ability on con-
necting with amyloid monomers.
Besides inhibiting the aggregation of Aβ and hIAPP, the 
compound with antioxidant activity can also prevent the cell 
destruction related to AD and T2D. Reactive oxygen species 
(ROS) is always produced by living organisms because of 
the cellular metabolism and environmental factors.14 In the 
AD and T2D, ROS can lead to the death of neuronal cells in 
the brain and also to β-cell destruction, which is related to 
insulin production. Oxidative stress, the shift of the balance 
between oxidants and antioxidants, contributes to many dis-
eases including neurological disorders, diabetes, and so on.
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scaveng-
ing assay was carried out to evaluate the antioxidant activity 
of RA, CA, and DPA, and all these compounds express the 
concentration-dependent antioxidant activity. As shown in 
Figure 4, RA shows the strongest antioxidant activity, the 
antioxidant rate reaching more than 80% with concentrations 
of 25 and 50 µM, even more significant than the positive 
control. DPA also shows the strong antioxidant activity (65% 
at 50 µM), while the antioxidant activity of CA is not signif-
icant (25% at 50 µM).
Bendary et al. found that the antioxidant activity is related 
to the compound structure, which in turn depends on the 
number and position of the functional groups such as 
hydroxyl group, amino group, and so on.15 In the structures 
of RA, CA, and DPA, RA has the most OH groups, and DPA 
includes more hydroxyl groups than CA. This may be the 
reason that the antioxidant intensity is ranked in RA, DPA, 
and CA.
In the present study, some relationship between AD and 
T2D has been found. Because Aβ and hIAPP play an 
Figure 3. TEM observation of Aβ and hIAPP. (a) 25 µM Aβ42; (b) 25 µM Aβ42 with 100 µM RA; (c) 25 µM Aβ42 with 100 µM CA; 
(d) 25 µM Aβ42 with 100 µM DPA; (e) 25 µM hIAPP; (f) 25 µM hIAPP with 100 µM RA; (g) 25 µM hIAPP with 100 µM CA; (h) 25 µM 
hIAPP with 100 µM DPA. Aβ, amyloid β; CA, caffeic acid; DPA, 3,4-dihydroxyphenyllactic acid; hIAPP, human islet amyloid polypeptide; RA, 
rosmarinic acid; TEM, transmission electron microscopy.
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important role in triggering AD and T2D, we suggested that 
it be necessary to find the compounds that can inhibit the 
protein fibrillization and show a strong antioxidant activity. 
In the structure of RA, CA, and DPA, the catechol moieties 
showed a significant influence on the inhibition of amyloid 
aggregation, while the hydroxyl groups expressed strong 
antioxidant activities. Both inhibitory activity and antioxi-
dant activity may show the protective effect and lead to effi-
cient therapy related on AD and T2D.
Also, as per the several reports on RA about its inhibitory 
activity toward Aβ and hIAPP aggregation,16,17 we believed 
that applying RA in medicine will be a promising strategy to 
treat and prevent AD and diabetes. The findings have inspired 
us to conduct more investigation on various biological activ-
ities of phenolic compounds from other medicinal plants 
apart from I. japonicus to get more useful guidelines in rela-
tion to search for novel RA-related inhibitors against protein 
aggregation associated with chronic diseases.
Experimental
Isolation of RA
Isodon japonicus (Burm.f.) H. Hara was purchased from Kanai 
Co., Ltd. (Tokyo, Japan). After smashing, the dried I. japonicus 
(100 g) was extracted with MeOH (700 mL ×2) at room tem-
perature for 24 hours. After filtration and evaporation, the 
MeOH extract was mixed with EtOAc (400 mL ×3) and H2O 
(400 mL). A portion (2 g) of EtOAc-soluble material (RJ-EA, 
4.37 g) was chromatographed over octadecylsilyl (ODS) col-
umn (Cosmosil 75C18-PREP, ϕ2.2 × 30 cm, acetone:H2O = 
3:7→1:0). RJ-EA-4 (260.5 mg) was separated using ODS col-
umn (Cosmosil 75C18-PREP, ϕ1.0 × 30 cm, MeOH:H2O = 
3:7→1:0) to afford RJ-EA-4–1~4-8. RJ-EA-4–3 (23.5 mg) 
was purified by TSKgel ODS-120A, MeOH-1% AcOH in 
water (30:70) to obtain RA (11.1 mg) and confirmed by 1H 
NMR spectrum (CD3OD, 500 MHz).
CA and DPA were purchased from FUJIFILM Wako Pure 
Chemical Corporation, Japan.
Th-T Fluorescence Assay
Aβ42 was dissolved in 0.1% NH4OH and hIAPP (KareBay 
Biochem Inc., USA) was dissolved in 1,1,1,3,3,3-hexafluo-
ro-2-propanol. The amyloid solution was diluted 10-fold 
with 50 mM phosphate-buffered saline (pH 7.4). Both pep-
tides were pretreated with 1, 10, and 100 µM of RA, CA, and 
DPA, in the 96-well microtiter plate (Thermo Scientific), 
respectively. All the samples were incubated for 24 hours at 
37°C. Th-T fluorescence intensity was evaluated at 0, 4, 8, 
and 24 hours, and found to show an excitation wavelength of 
420 nm and an emission wavelength of 485 nm.
Transmission Electronic Microscopy
Aβ42 and hIAPP (each 25 µM) treated with equimolar RA, 
CA, and DPA were spotted onto a carbon-coated Formvar 
grid and incubated for 2 minutes at room temperature and 
air-dried for 5 minutes after washing by H2O twice and 0.4% 
silicotungstic solution twice. Samples were observed under 
the JEOL JEM-1400 electron microscope.
DPPH Radical Scavenging Assay
DPPH radical scavenging assay was applied to evaluate the 
antioxidant activity of RA, CA, and DPA. The positive con-
trol epigallocatechin gallate and the three compounds were 
pretreated to 5, 25, and 50 µM, and 10 µL of each sample 
was injected into a 96-well plate. Half were treated with 190 
µL of DPPH solution [combined DPPH (1.9 mg)/12.0 mL 
EtOH, 3.0 mL of 2-(N-morpholino)ethanesulfonic acid 
(MES), and 9.0 mL of H2O], and half were treated without 
DPPH (combined EtOH 1.0 mL, 3.0 mL of MES, and 9.0 mL 
of H2O). After a 15 min reaction at room temperature, both 
samples were examined under the wavelength of 490 nm.
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